Bhavyam Pharmacy Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 17-12-2024
- Paid Up Capital ₹ 1.94 M
as on 17-12-2024
- Company Age 7 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.22 M
as on 17-12-2024
- Revenue -14.86%
(FY 2023)
- Profit -927.30%
(FY 2023)
- Ebitda -398.12%
(FY 2023)
- Net Worth -74.75%
(FY 2023)
- Total Assets -2.50%
(FY 2023)
About Bhavyam Pharmacy
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.94 M.
The company currently has active open charges totaling ₹0.22 M.
Meenakshi, Jitender Kapoor, and Vedant Nagar serve as directors at the Company.
- CIN/LLPIN
U51909HR2017PTC069096
- Company No.
069096
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 May 2017
- Date of AGM
30 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Faridabad, Haryana, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Bhavyam Pharmacy Private Limited offer?
Bhavyam Pharmacy Private Limited offers a wide range of products and services, including Common Disease Medicines, Allopathic Cough Syrup.
Who are the key members and board of directors at Bhavyam Pharmacy?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Meenakshi  | Director | 19-May-2017 | Current |
| Jitender Kapoor | Director | 19-May-2017 | Current |
| Vedant Nagar | Director | 28-Jan-2021 | Current |
Financial Performance of Bhavyam Pharmacy.
Bhavyam Pharmacy Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 14.86% decrease. The company also saw a substantial fall in profitability, with a 927.3% decrease in profit. The company's net worth observed a substantial decline by a decrease of 74.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bhavyam Pharmacy?
Unlock access to Bhavyam Pharmacy's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 28 Apr 2021 | ₹0.22 M | Open |
How Many Employees Work at Bhavyam Pharmacy?
Unlock and access historical data on people associated with Bhavyam Pharmacy, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bhavyam Pharmacy, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bhavyam Pharmacy's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
